Teijin Co., Ltd., Japan Tissue Engineering Co., Ltd., the National Cancer Research Center and Mitsui Fudosan Co., Ltd. are jointly building a "regenerative medicine platform" in Kashiwanoha Smart City that realizes one-stop processes from research and development of products such as regenerative medicine to business planning and commercial production (PR information dated September 27, 2022) with the aim of creating innovative treatments for unresolved diseases such as cancer.
The homepage of Kashiwa-no-ha "Regenerative Medicine Platform" has been opened, so please take a look.
Click here for the homepage of Kashiwa-no-ha "Regenerative Medicine Platform"
Click here for PR information on September 27, 2022
“Regenerative medicine platform that realizes one-stop creation of innovative treatments for unresolved diseases such as cancer” Construction in Kashiwa-no-ha, Chiba Prefecture through industry-academia collaboration